275 related articles for article (PubMed ID: 22640433)
1. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers.
Kauvar AN
Semin Cutan Med Surg; 2012 Jun; 31(2):126-32. PubMed ID: 22640433
[TBL] [Abstract][Full Text] [Related]
2. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
Brown AS; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
[TBL] [Abstract][Full Text] [Related]
3. Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium:yttrium-aluminium-garnet laser.
Kim JE; Chang SE; Yeo UC; Haw S; Kim IH
Clin Exp Dermatol; 2013 Mar; 38(2):167-71. PubMed ID: 23397944
[TBL] [Abstract][Full Text] [Related]
4. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
5. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma.
Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK
Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
Aurangabadkar SJ
Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
[TBL] [Abstract][Full Text] [Related]
7. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling.
Vachiramon V; Sahawatwong S; Sirithanabadeekul P
Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
[TBL] [Abstract][Full Text] [Related]
9. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
10. Commentary on Clinical and Histopathological Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Morton LM
Dermatol Surg; 2016 Apr; 42(4):513-4. PubMed ID: 26949932
[No Abstract] [Full Text] [Related]
11. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy.
Ryu HJ; Kim J
J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754
[TBL] [Abstract][Full Text] [Related]
12. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
Moubasher AE; Youssef EM; Abou-Taleb DA
Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
[TBL] [Abstract][Full Text] [Related]
13. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
14. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
15. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
[TBL] [Abstract][Full Text] [Related]
16. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma.
Kar HK; Gupta L; Chauhan A
Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647
[TBL] [Abstract][Full Text] [Related]
17. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
18. Epidermal grafting for leukoderma resulting from 1064-nm quality-switched neodymium-doped yttrium aluminium garnet laser toning.
Wang YJ; Chang CC
Int Wound J; 2018 Dec; 15(6):1045-1048. PubMed ID: 30014596
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
Kauvar AN
Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
[TBL] [Abstract][Full Text] [Related]
20. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
